A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Colorado, Denver
AbbVie
University of Rochester
Wake Forest University Health Sciences
University of Nebraska
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Gamida Cell ltd
University of Colorado, Denver
University of Rochester
Chang Gung University
Brown University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Astellas Pharma Inc
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
Takeda
Therapeutic Advances in Childhood Leukemia Consortium
AbbVie
Astellas Pharma Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Astellas Pharma Inc
Stanford University
Center for International Blood and Marrow Transplant Research
Celgene
Masonic Cancer Center, University of Minnesota
Novo Nordisk A/S
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Big Ten Cancer Research Consortium
Thomas Jefferson University
Menarini Group
Thomas Jefferson University
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Washington University School of Medicine
National Cancer Institute (NCI)
Pfizer